Craig Gassman
Craig joined Vericel in 2017 and brings more than 20 years of leadership experience in the life sciences industry across a broad range of biotechnology organizations. He leads the company’s enterprise information technology strategy, enabling scalable, compliant, and high-performing operations across the organization. Craig’s background includes progressive technology and regulatory leadership roles at Genzyme, Biogen, AVEO Oncology, BioVex, Amgen, and Karyopharm Therapeutics. Craig holds a B.S. in Microbiology from the University of Massachusetts Amherst and an M.S. in Regulatory Affairs from Northeastern University.